本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Teladoc Health Inc.

6.19
-0.0150-0.24%
成交量:155.27萬
成交額:957.00萬
市值:11.24億
市盈率:-6.23
高:6.27
開:6.24
低:6.12
收:6.20
52周最高:9.89
52周最低:4.40
股本:1.82億
流通股本:1.81億
量比:0.61
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-0.9925
每股收益(LYR):-1.1400
淨資產收益率:-12.99%
總資產收益率:-3.22%
市淨率:0.86
市盈率(LYR):-5.43

資料載入中...

2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/21

重要事件披露

Form 8-K - Current report
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors